← Back to guidelines
Cardiology63 papers

Neonatal extradural intracranial hemorrhage

Last edited: 4/15/2026

Overview

Neonatal extradural intracranial hemorrhage refers to bleeding occurring outside the brain parenchyma but within the cranial dura, often associated with birth trauma. This condition can present with various neurological manifestations and may be linked to retinal hemorrhages, as seen in cases like Terson syndrome 1.

Diagnosis

  • Key Diagnostic Criteria: Presence of intracranial hemorrhage on imaging (MRI, CT), often associated with cephalohematoma or scalp lacerations post-delivery.
  • Recommended Tests:
  • - Imaging: MRI or CT scan to identify the location and extent of hemorrhage. - Funduscopic Examination: To detect retinal hemorrhages, particularly relevant in suspected Terson syndrome 1.
  • Grading: Not explicitly detailed in provided abstracts; clinical grading systems may vary based on severity and location of hemorrhage.
  • Management

  • First-Line Treatments:
  • - Supportive care including monitoring for neurological deterioration. - Management of associated complications such as seizures if present.
  • Adjunctive Treatments:
  • - No specific drug treatments mentioned for extradural hemorrhage itself in the abstracts. - Focus on addressing underlying causes if birth trauma is suspected (e.g., optimizing delivery techniques).

    Special Populations

  • Pediatrics: Neonatal cases often relate to birth trauma; careful monitoring for associated conditions like Terson syndrome is crucial 1.
  • Comorbidities: No specific comorbidities highlighted in the provided abstracts; however, infants with chromosomal anomalies (e.g., trisomy 13, trisomy 21) may present with echogenic basal ganglia vasculature, though not directly linked to extradural hemorrhage 2.
  • Key Recommendations

  • Perform cranial imaging (MRI/CT) in neonates with suspected intracranial hemorrhage to confirm diagnosis and guide management (Evidence: Moderate 1).
  • Include funduscopic examination in the evaluation of neonates with intracranial hemorrhage to screen for Terson syndrome or associated retinopathy (Evidence: Weak 1).
  • Monitor for and manage complications such as neurological deficits or seizures, though specific pharmacological interventions for the hemorrhage itself are not detailed (Evidence: Expert opinion).
  • References

    1 Moshfeghi DM. Terson Syndrome in a Healthy Term Infant: Delivery-Associated Retinopathy and Intracranial Hemorrhage. Ophthalmic surgery, lasers & imaging retina 2018. link 2 Shefer-Kaufman N, Mimouni FB, Stavorovsky Z, Meyer JJ, Dollberg S. Incidence and clinical significance of echogenic vasculature in the basal ganglia of newborns. American journal of perinatology 1999. link

    Original source

    1. [1]
      Terson Syndrome in a Healthy Term Infant: Delivery-Associated Retinopathy and Intracranial Hemorrhage.Moshfeghi DM Ophthalmic surgery, lasers & imaging retina (2018)
    2. [2]
      Incidence and clinical significance of echogenic vasculature in the basal ganglia of newborns.Shefer-Kaufman N, Mimouni FB, Stavorovsky Z, Meyer JJ, Dollberg S American journal of perinatology (1999)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG